Pincus & Co. Warburg Sells 9,720,000 Shares of Sotera Health (NASDAQ:SHC) Stock

Sotera Health Company (NASDAQ:SHC) Director Pincus & Co. Warburg sold 9,720,000 shares of the firm’s stock in a transaction on Wednesday, December 3rd. The shares were sold at an average price of $16.33, for a total value of $158,727,600.00. Following the sale, the director directly owned 34,102,952 shares of the company’s stock, valued at $556,901,206.16. This represents a 22.18% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Pincus & Co. Warburg also recently made the following trade(s):

• On Monday, November 10th, Pincus & Co. Warburg sold 18,000,000 shares of Sotera Health stock. The stock was sold at an average price of $15.65, for a total transaction of $281,700,000.00.

Sotera Health Price Performance

Sotera Health stock opened at $16.75 on Friday. The company has a market capitalization of $4.76 billion, a price-to-earnings ratio of 88.16 and a beta of 1.81. The company has a current ratio of 2.38, a quick ratio of 2.18 and a debt-to-equity ratio of 4.04. Sotera Health Company has a 12 month low of $9.53 and a 12 month high of $17.78. The stock’s 50 day moving average is $16.31 and its 200-day moving average is $14.36.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings results on Tuesday, November 4th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.04. Sotera Health had a return on equity of 43.69% and a net margin of 4.82%.The business had revenue of $311.31 million during the quarter, compared to analysts’ expectations of $303.63 million. Sotera Health has set its FY 2025 guidance at 0.810-0.860 EPS. Equities research analysts expect that Sotera Health Company will post 0.61 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in SHC. Alpine Global Management LLC acquired a new position in Sotera Health during the third quarter valued at approximately $342,000. Voss Capital LP raised its holdings in shares of Sotera Health by 146.7% during the 3rd quarter. Voss Capital LP now owns 1,850,000 shares of the company’s stock worth $29,100,000 after buying an additional 1,100,000 shares in the last quarter. Captrust Financial Advisors bought a new stake in shares of Sotera Health during the 3rd quarter worth $3,505,000. Woodline Partners LP acquired a new stake in Sotera Health in the third quarter valued at about $8,348,000. Finally, Scientech Research LLC acquired a new stake in Sotera Health in the third quarter valued at about $310,000. 91.03% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Weiss Ratings restated a “hold (c-)” rating on shares of Sotera Health in a research note on Tuesday. Wall Street Zen upgraded shares of Sotera Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 16th. Piper Sandler lifted their price target on shares of Sotera Health from $15.00 to $17.00 and gave the company a “neutral” rating in a research report on Wednesday, November 5th. Barclays boosted their price target on Sotera Health from $19.00 to $20.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. Finally, JPMorgan Chase & Co. raised their price objective on Sotera Health from $14.00 to $16.00 and gave the stock a “neutral” rating in a research note on Wednesday, November 5th. Three equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, Sotera Health presently has an average rating of “Moderate Buy” and a consensus price target of $17.80.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.